June 5 (Reuters) - CSL Ltd (CSL) :
- INJECTAFER APPROVED IN U.S. FOR TREATMENT OF IRON DEFICIENCY IN PATIENTS WITH HEART FAILURE
News: CSL CSL Ltd Says Injectafer Approved In U.S.
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$286.76 |
Change
3.710(1.31%) |
Mkt cap ! $138.3B | |||
| Open | High | Low | Value | Volume |
| $286.49 | $286.79 | $284.10 | $40.98M | 143.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 56 | $286.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $286.78 | 4 | 1 |
View Market Depth
| Last trade - 10.56am 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$287.10 |
Change
3.710 ( 1.10 %) |
||||
| Open | High | Low | Volume | ||
| $286.01 | $287.16 | $284.18 | 7798 | ||
| Last updated 11.15am 16/05/2024 ? | |||||
| CSL (ASX) Chart |